Ascendis Pharma Management

Management Kriterienprüfungen 2/4

Ascendis Pharma CEO ist Jan Mikkelsen , ernannt in Dec 2007, hat eine Amtszeit von 16.92 Jahren. besitzt direkt 0.71% der Aktien des Unternehmens, im Wert von $54.23M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 8.3 Jahre bzw. 6.8 Jahre.

Wichtige Informationen

Jan Mikkelsen

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehaltsn/a
Amtszeit als Geschäftsführer16.9yrs
Eigentum des Geschäftsführers0.7%
Durchschnittliche Amtszeit des Managements8.3yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder6.8yrs

Jüngste Management Updates

Recent updates

Ascendis Pharma Takes A Big Price Cut On Skytrofa

Sep 05

Ascendis Pharma A/S' (NASDAQ:ASND) Share Price Could Signal Some Risk

Jul 20
Ascendis Pharma A/S' (NASDAQ:ASND) Share Price Could Signal Some Risk

Some Confidence Is Lacking In Ascendis Pharma A/S' (NASDAQ:ASND) P/S

Apr 05
Some Confidence Is Lacking In Ascendis Pharma A/S' (NASDAQ:ASND) P/S

Ascendis Pharma's Ambitious Vision 2030

Jan 11

What Ascendis Pharma A/S' (NASDAQ:ASND) 29% Share Price Gain Is Not Telling You

Dec 21
What Ascendis Pharma A/S' (NASDAQ:ASND) 29% Share Price Gain Is Not Telling You

Is Ascendis Pharma (NASDAQ:ASND) Using Debt Sensibly?

Nov 10
Is Ascendis Pharma (NASDAQ:ASND) Using Debt Sensibly?

Ascendis Pharma A/S' (NASDAQ:ASND) Popularity With Investors Is Under Threat From Overpricing

Oct 05
Ascendis Pharma A/S' (NASDAQ:ASND) Popularity With Investors Is Under Threat From Overpricing

Is Ascendis Pharma (NASDAQ:ASND) Using Debt Sensibly?

Jun 27
Is Ascendis Pharma (NASDAQ:ASND) Using Debt Sensibly?

Analysts Are Betting On Ascendis Pharma A/S (NASDAQ:ASND) With A Big Upgrade This Week

May 05
Analysts Are Betting On Ascendis Pharma A/S (NASDAQ:ASND) With A Big Upgrade This Week

Is Ascendis Pharma (NASDAQ:ASND) Using Debt In A Risky Way?

Feb 18
Is Ascendis Pharma (NASDAQ:ASND) Using Debt In A Risky Way?

Is Ascendis Pharma (NASDAQ:ASND) A Risky Investment?

Sep 24
Is Ascendis Pharma (NASDAQ:ASND) A Risky Investment?

Ascendis Pharma: TransCon CNP Data Coming Q4

Sep 15

Ascendis Pharma seeks FDA nod for its parathyroid hormone restorer TransCon PTH

Aug 31

Ascendis Pharma Q2 results beat buoyed by strong sales of growth hormone drug Skytrofa

Aug 11

Ascendis Pharma: Institutional Buying Values Dutch Biotech Best-Now Cap-Gain Prospect

Aug 03

Here's Why Ascendis Pharma (NASDAQ:ASND) Can Manage Its Debt Despite Losing Money

Jun 10
Here's Why Ascendis Pharma (NASDAQ:ASND) Can Manage Its Debt Despite Losing Money

Geschäftsführer

Jan Mikkelsen (64 yo)

16.9yrs

Amtszeit

Mr. Jan Moller Mikkelsen serves as the Chief Executive Officer, President, Executive Director and Member of Executive Board of Ascendis Pharma A/S since December 2007. He is Director at Eyconis, Inc. He se...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Jan Mikkelsen
President16.9yrskeine Daten0.71%
$ 54.2m
Scott Smith
CFO, Executive VP & Member of Executive Board8.3yrskeine Daten0.0067%
$ 514.6k
Lotte Sonderbjerg
Executive VP16.9yrskeine Daten0.0031%
$ 238.1k
Michael Jensen
Executive VP11.4yrskeine Daten0.0032%
$ 247.3k
Mads Bodenhoff
Senior VP of Finance & Principal Accounting Officerless than a yearkeine Datenkeine Daten
Timothy Lee
Senior Director of Investor Relationsno datakeine Datenkeine Daten
Flemming Jensen
Executive Vice President of Product Supply & Quality9.3yrskeine Daten0.0031%
$ 238.1k
Kennett Sprogoe
Executive VP and Head of Research & Product Development8.8yrskeine Daten0.0048%
$ 369.8k
Stina Singel
Executive VP & Head of Clinical Development for Oncology2.8yrskeine Datenkeine Daten
Joseph Kelly
Head of U.S. Commercial of Endocrinology2.5yrskeine Datenkeine Daten
Scott Holmes
Head of Global Commercial Strategy of Endocrinology2.5yrskeine Datenkeine Daten
Camilla Hartvig
Executive VP & Global Chief Commercial Officer1.4yrskeine Datenkeine Daten

8.3yrs

Durchschnittliche Betriebszugehörigkeit

54yo

Durchschnittliches Alter

Erfahrenes Management: ASNDDas Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (8.3 ).


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Jan Mikkelsen
President16.9yrskeine Daten0.71%
$ 54.2m
Albert Cha
Independent Chairman10yrs€139.72k0.00065%
$ 49.8k
William Fairey
Independent Director2.2yrs€73.01k0%
$ 0
Lisa Morrison
Independent Director7.6yrs€92.64k0.00065%
$ 49.8k
Lars Holtug
Independent Director6yrs€96.17k0.0015%
$ 114.1k
Siham Imani
Independent Director2.2yrs€69.48k0%
$ 0

6.8yrs

Durchschnittliche Betriebszugehörigkeit

58yo

Durchschnittliches Alter

Erfahrener Vorstand: ASNDDie Vorstandsmitglieder gelten als erfahren (6.8 Jahre durchschnittliche Amtszeit).